CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill imprint CYP 517 has been identified as Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg.

Uritact-EC is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CYP 517

Uritact-EC
Generic Name:
hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint:
CYP 517
Strength:
0.06 mg-81.6 mg-10.8 mg-36.2 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cypress Pharmaceutical Inc

View Details Print Page

More about Uritact-EC (hyoscyamine / methenamine / methylene blue / phenyl salicylate)

Consumer resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)